Providers review chronic conditions, current medications, previous treatments, family history, nutrition, exercise habits, sleep quality, stress levels, and personal treatment goals
This Review provides insights into the physiology of GLP1 and its involvement in the pathophysiology of T2DM and an overview of the currently available and emerging GLP1RAs
It has the strongest human evidence of anything in this group, and that evidence is genuinely mixed
Follow-up and ongoing monitoring are part of our care plan We believe in complete transparency
Maintain internal records that document how compounded GLP-1 products are described, sourced, and communicated throughout the patient service process